Subscribe
Back to list

Antony Gobin

Chief Pharmacy Officer and Vice President of Pharmacy

Loma Linda University Health

Loma Linda, CA

Dr. Gobin provides executive leadership and strategic oversight for pharmacy services across Loma Linda University Health, a multi-hospital academic system, with responsibility for inpatient hospitals, ambulatory infusion centers, outpatient pharmacies, specialty pharmacy services and home health pharmacy programs. He has led systemwide initiatives advancing medication safety, optimizing operations and expanding patient access, including the opening of new outpatient pharmacies and the development of specialty and ambulatory pharmacy programs. Dr. Gobin played a key leadership role in onboarding and integrating cellular and gene therapy programs, helping establish the pharmacy infrastructure required to support those complex treatments. He has invested in building pharmacy leadership across the organization, mentoring emerging leaders and expanding the number of pharmacy specialists on patient care teams. As an associate professor at the Loma Linda University School of Pharmacy, he contributes to the education and mentorship of future pharmacists. Earlier in his career, Dr. Gobin held progressive roles including clinical pharmacist, pharmacy supervisor, medication safety pharmacist and director of pharmacy.

Becker's Recognition

Antony Gobinhas been named a Becker's honoree on the lists below.

2026 Winner

Executives

101 Hospital and Health System Chief Pharmacy Officers to Know

Chief pharmacy officers provide systemwide oversight of medication management and drug supply, which in turn creates a safer patient experience. These executives are also responsible for leading cost-effective pharmacy strategy, implementing impactful pharmacy policies, driving automation and technology initiatives, and educating the next generation of pharmacy leaders.

Newsletter

Join the 500,000+
healthcare executives
who start their day with
Becker’s

You can unsubscribe from these communications at any time. For more information, please review
our Privacy Policy.
More Newsletters